CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO)

CUSIP: 71902K105

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
5,169,697
Total 13F shares
13,323,470
Share change
+9,881,208
Total reported value
$956,030
Price per share
$0.06
Number of holders
19
Value change
+$580,962
Number of buys
15
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 71902K105?
CUSIP 71902K105 identifies CERO - CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) as of Q4 2024

As of 31 Dec 2024, CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,323,470 shares. The largest 10 holders included ARCH Venture Management, LLC, Avantax Planning Partners, Inc., Cubist Systematic Strategies, LLC, Vanguard Personalized Indexing Management, LLC, GOLDMAN SACHS GROUP INC, CANTOR FITZGERALD, L. P., Selkirk Management LLC, Tower Research Capital LLC (TRC), MILLENNIUM MANAGEMENT LLC, and JANE STREET GROUP, LLC. This page lists 19 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.